Revance Therapeutics, Inc. (RVNC)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Balance Sheet
All numbers in thousandsBreakdown
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
137,329
108,965
110,623
333,558
Other Short Term Investments
116,586
231,742
114,448
102,947
Total Cash
253,915
340,707
225,071
436,505
Net Receivables
27,676
11,339
3,348
1,829
Inventory
45,579
18,325
10,154
5,876
Other Current Assets
11,145
4,356
7,544
5,793
Total Current Assets
338,865
374,727
246,117
450,003
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
90,207
59,415
92,330
66,622
Accumulated Depreciation
-
-28,592
-23,329
-19,491
Net property, plant and equipment
90,207
59,415
69,001
47,131
Goodwill
0
77,175
146,964
146,964
Intangible Assets
9,808
35,344
55,334
71,343
Other long-term assets
7,191
7,739
6,047
4,779
Total non-current assets
139,589
207,173
285,046
270,217
Total Assets
478,454
581,900
531,163
720,220
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
2,500
-
-
-
Accounts Payable
13,809
4,546
10,603
12,657
Accrued liabilities
19,508
28,030
15,355
14,092
Deferred revenues
10,737
6,867
9,362
7,851
Other Current Liabilities
3,184
3,313
4,462
4,553
Total Current Liabilities
89,224
75,682
67,289
60,964
Non-current liabilities
Long Term Debt
426,595
379,374
280,635
180,526
Deferred revenues
70,419
78,577
74,152
77,294
Other long-term liabilities
2,835
1,485
1,485
-
Total non-current liabilities
540,834
493,618
395,403
284,966
Total Liabilities
630,058
569,300
462,692
345,930
Stockholders' Equity
Common Stock
88
82
72
69
Retained Earnings
-2,078,360
-1,754,374
-1,397,952
-1,126,293
Accumulated other comprehensive income
14
-374
-18
0
Total stockholders' equity
-151,604
12,600
68,471
374,290
Total liabilities and stockholders' equity
478,454
581,900
531,163
720,220
© 2024 Yahoo. All rights reserved.